About Kiwi Biosciences
Kiwi Biosciences can help 18M Americans suffering from Irritable Bowel Syndrome (IBS) enjoy a normal meal without running to the bathroom two hours later. We develop novel, patent-pending enzymes that break down common digestive triggers in food.
Founders & Key People
Financials Beta
Business Model: Not Specified
Revenues: Not Specified
Expenses: Not Specified
Debt: Request
Operating Status: Active
Funding Raised: $0
Investment Rounds: 0 Rounds
Funding Stage: Not Specified
Last Funding Date: Not Specified